In this free webinar, gain insights into how specific proteins can indicate the severity of metabolic disorders and provide a better understanding of the pathogenesis of cardiovascular disease in diabetic patients. The presenter will explain how NGS-based proteomics was leveraged to identify key biomarkers that differentiate healthy individuals from those with metabolic conditions, further stratifying them into prediabetic and Type 2 diabetes stages. Biomarkers linking diabetes to heart disease will also be presented. Finally, there will be a discussion on plasma proteomics analysis and its applications in identifying cardiometabolic signatures.
TORONTO, March 26, 2025 /PRNewswire-PRWeb/ -- Glucose metabolism disturbances, particularly type 2 diabetes (T2D), are significant risk factors for cardiovascular diseases. However, the biomarkers for atherosclerosis development in patients with T2D or prediabetes remain largely unexplored.
In this webinar, the cardiovascular expert Prof. Karol Kaminski, MD, PhD, will present a study that contributes to closing this gap in research. This study identified proteomic biomarkers in individuals with untreated glucose metabolism disturbances who are not diagnosed with diabetes, chronic inflammatory, neoplastic or cardiovascular disease.
Using an innovative high-throughput proteomic analysis method, which measures approximately 1,000 abundance proteins in plasma across a wide range of biological pathways, numerous proteins have been identified that distinguish healthy controls from those with prediabetes and T2D.
Register for this webinar to gain insights into how specific proteins can indicate more severe metabolic disorders and provide a better understanding of the pathogenesis of cardiovascular disease in diabetic patients.
Join Prof. Karol Kaminski, MD, PhD, Cardiologist, Professor, Medical University of Bialystok; and Fanny Taborsak-Lines, MSc, Technical Product Manager, Olink Proteomics (Part of Thermo Fisher Scientific), for the live webinar on Wednesday, April 16, 2025, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Uncovering Proteomic Biomarkers Linking Type 2 Diabetes to Cardiovascular Risk.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], www.xtalks.com
SOURCE Xtalks
Share this article